Business Context and Reporting Period
Company: American Shared Hospital Services (ASHS)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2010
Business Overview: ASHS provides Gamma Knife units to 19 medical centers and offers radiation therapy equipment services. The company also holds a significant investment in Still River Systems, Inc., a developer of proton beam radiation therapy (PBRT) systems.
Key Financial Metrics
| Metric | Q1 2010 | Q1 2009 |
|---|---|---|
| Medical Services Revenue | $4,088,000 | $4,167,000 |
| Gross Margin | $1,699,000 (41.6%) | $1,597,000 (38.3%) |
| Operating Income | $157,000 | ($76,000) |
| Net Income (Consolidated) | $177,000 | $51,000 |
| Net Income Attributable to ASHS | $8,000 | ($94,000) |
| Diluted EPS | $0.00 | ($0.02) |
| Cash and Cash Equivalents | $552,000 | $9,546,000 (Q1 2009) |
| Net Cash from Operating Activities | $1,236,000 | $1,462,000 |
| Total Debt (Current + Long-term) | $25,596,000 | N/A |
| Line of Credit Utilization | $8,300,000 | $7,900,000 (Dec 31, 2009) |
Material Changes vs. Prior Period
- Revenue Decline: Medical services revenue decreased by $79,000 (1.9%) primarily due to one Gamma Knife site performing zero procedures following physician turnover and a shift in volume to sites with lower payment rates, despite a 7-procedure increase in total volume.
- Profitability Improvement: The company returned to profitability for the quarter, reporting $8,000 in net income attributable to shareholders compared to a $94,000 loss in Q1 2009. This was driven by a $181,000 reduction in costs of revenue and the absence of $197,000 in transaction costs incurred in the prior year.
- Cost Reductions: Depreciation and amortization decreased by $140,000 due to extended asset lives and the cessation of depreciation on a unit being traded in. Maintenance costs also declined.
- Expense Increases: Selling and administrative expenses rose by $68,000 due to increased legal fees for new business development.
- Cash Position: Cash and cash equivalents dropped significantly from $833,000 at year-end 2009 to $552,000 at March 31, 2010, driven by debt principal payments and equipment purchases.
Outlook, Risks, and Contingencies
- Capital Commitments: The company has approximately $43,000,000 in remaining commitments to purchase equipment, including three Monarch250 proton beam systems from Still River and multiple Gamma Knife units.
- Financing Risks: Management notes that obtaining financing for future projects has become more difficult due to economic conditions. Financing for PBRT systems is contingent on Still River receiving FDA approval.
- Investment Impairment: ASHS holds a $2,617,000 investment in Still River Systems. While a Series D financing round resulted in an unrealized loss of approximately $1.2 million, management deems the impairment "temporary" and intends to hold the investment.
- Liquidity: The company maintains a $9,000,000 line of credit, of which $8,300,000 is currently drawn. Management believes cash flow from operations is adequate to meet scheduled debt obligations for the next 12 months.
Key Facts for Investor Verification
- Revenue Concentration: Verify the impact of the single Gamma Knife site with zero procedures and the stability of payment rates across the 19 operating sites.
- Still River Viability: Assess the timeline for FDA approval of the Monarch250 system, as this is critical for the realization of the $2.25 million in deposits and the $43 million in total equipment commitments.
- Debt Service: Confirm the company's ability to service approximately $5.5 million in debt principal and interest and $2.45 million in capital lease payments due in the next 12 months given the low cash balance of $552,000.
- Non-Controlling Interest: Note that the majority of consolidated net income ($169,000 of $177,000) is attributable to the non-controlling interest in GK Financing, leaving minimal earnings for common shareholders.